Skip to main content Accessibility help
×
Hostname: page-component-857557d7f7-zv5th Total loading time: 0 Render date: 2025-12-08T00:30:09.730Z Has data issue: false hasContentIssue false

Chapter 11 - Ovarian Stimulation in Poor Responders

from Section 2 - Ovarian Hyperstimulation for IVF

Published online by Cambridge University Press:  14 April 2022

By
Qiuju Chen  and
Yanping Kuang
Edited by
Mohamed Aboulghar  and
Botros Rizk
Mohamed Aboulghar
Affiliation:
University of Cairo IVF Centre
Botros Rizk
Affiliation:
University of South Alabama
Get access

Summary

Controlled ovarian stimulation (COS) is an important step during in vitro fertilization (IVF) treatment that aims to produce sufficient follicles and oocytes to achieve pregnancy. Despite recent progresses in assisted reproductive technology (ART), a poor ovarian response (POR) remains one of the most challenging issues for reproductive clinicians [1]. The incidence of POR during COS has been reported to range from 5.6 percent to 35.1 percent depending on differences in the definition of poor response [1–4]. Patients with POR have higher cycle cancellation rates, lower pregnancy rates, and heavier financial burden [4–6]. In this chapter, we discuss the classification and treatments of POR.

Information

Type
Chapter
Information
Ovarian Stimulation , pp. 101 - 108
Publisher: Cambridge University Press
Print publication year: 2022

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Book purchase

Temporarily unavailable

References

Oudendijk, JF, Yarde, F, Eijkemans, MJ, Broekmans, FJ, Broer, SL. The poor responder in IVF: is the prognosis always poor? a systematic review. Hum Reprod Update 2012;18:1–11.Google Scholar
Bosdou, JK, Venetis, CA, Kolibianakis, EM, et al. The use of androgens or androgen modulating agents in poor responders undergoing in vitro fertilization: a systematic review and meta-analysis. Hum Reprod Update 2012;18:127–145.Google Scholar
Papathanasiou, A, Searle, BJ, King, NM, Bhattacharya, S. Trends in ‘poor responder’ research: lessons learned from RCTs in assisted conception. Hum Reprod Update 2016;22:306–319.Google Scholar
Surrey, ES, Schoolcraft, WB. Evaluating strategies for improving ovarian response of the poor responder undergoing assisted reproductive techniques. Fertil Steril 2000;73:667–676.Google Scholar
Papathanasiou, A. Implementing the ESHRE “poor responder” criteria in research studies: methodological implications. Hum Reprod 2014;29:1835–1838.Google Scholar
Polyzos, NP, Devroey, P. A systematic review of randomized trials for the treatment of poor ovarian responders: is there any light at the end of the tunnel? Fertil Steril 2011;96:1058–1061.Google Scholar
Ferraretti, AP, La Marca, A, Fauser, BC, et al. ESHRE consensus on the definition of ‘poor response’ to ovarian stimulation for in vitro fertilization: the Bologna criteria. Hum Reprod 2011;26:1616–1624.Google Scholar
Ferraretti, AP, Gianaroli, L. The Bologna criteria for the definition of poor ovarian responders: is there a need for revision? Hum Reprod 2014;29:1842–1845.CrossRefGoogle Scholar
Venetis, CA. The Bologna criteria for poor ovarian response: the good, the bad and the way forward. Hum Reprod 2014;29:1839–1841.Google Scholar
Younis, JS. The Bologna criteria for poor ovarian response; has the job been accomplished. Hum Reprod 2012;27:1874–1875.Google Scholar
Poseidon Group (Patient-Oriented Strategies Encompassing IndividualizeD Oocyte Number); Alviggi, C, Andersen, CY, Buehler, K, et al. A new more detailed stratification of low responders to ovarian stimulation: from a poor ovarian response to a low prognosis concept. Fertil Steril 2016;105:1452–1453.Google Scholar
Esteves, SC, Alviggi, C, Humaidan, P, et al. The POSEIDON criteria and its measure of success through the eyes of clinicians and embryologists. Front Endocrinol (Lausanne) 2019;10:814.Google Scholar
Humaidan, P, La Marca, A, Alviggi, C, Esteves, SC, Haahr, T. Future perspectives of POSEIDON stratification for clinical practice and research. Front Endocrinol (Lausanne) 2019;10:439.Google Scholar
Leijdekkers, JA, Eijkemans, MJC, van Tilborg, TC, et al. Cumulative live birth rates in low-prognosis women. Hum Reprod 2019;34:1030–1041.Google Scholar
Shi, W, Zhou, H, Tian, L, et al. Cumulative live birth rates of good and low prognosis patients according to POSEIDON criteria: a single center analysis of 18,455 treatment cycles. Front Endocrinol (Lausanne) 2019;10:409.Google Scholar
ESHRE Reproductive Endocrinology Guideline Group. Ovarian stimulation for IVF/ICSI: guideline of the European Society of Human Reproduction and Embryology. https://www.eshre.eu/Guidelines-and-Legal/Guidelines/Ovarian-Stimulation-in-IVF-ICSI.Google Scholar
Al-Inany, HG, Youssef, MA, Ayeleke, RO, et al. Gonadotrophin-releasing hormone antagonists for assisted reproductive technology. Cochrane Database Syst Rev 2016;4:CD001750.Google Scholar
Kuang, Y, Chen, Q, Fu, Y, et al. Medroxy progesterone acetate is an effective oral alternative for preventing premature luteinizing hormone surges in women undergoing controlled ovarian hyperstimulation for in vitro fertilization. Fertil Steril 2015;104:62–70.Google Scholar
Zhang, J, Wang, Y, Mao, X, et al. Dual trigger of final oocyte maturation in poor ovarian responders undergoing IVF/ICSI cycles. Reprod Biomed Online 2017;35:701–707.Google Scholar
Sunkara, SK, Ramaraju, GA, Kamath, MS. Management strategies for POSEIDON group 2. Front Endocrinol (Lausanne) 2020;11:105.Google Scholar
Gallot, V, Berwanger da Silva, AL, Genro, V, et al. Antral follicle responsiveness to follicle-stimulating hormone administration assessed by the follicular output RaTe (FORT) may predict in vitro fertilization-embryo transfer outcome. Hum Reprod 2012;27:1066–1072.CrossRefGoogle ScholarPubMed
Alviggi, C, Conforti, A, Esteves, SC, et al. Understanding ovarian hypo-response to exogenous gonadotropin in ovarian stimulation and its new proposed marker-the follicle-to-oocyte (FOI) index. Front Endocrinol (Lausanne) 2018;9:589.Google Scholar
Benmachiche, A, Benbouhedja, S, Zoghmar, A, Humaidan, P. Low LH level on the day of GnRH agonist trigger is associated with reduced ongoing pregnancy and live birth rates and increased early miscarriage rates following IVF/ICSI treatment and fresh embryo transfer. Front Endocrinol (Lausanne) 2019;10:639.CrossRefGoogle Scholar
Propst, AM, Hill, MJ, Bates, GW, et al. Low dose human chorionic gonadotropin may improve in vitro fertilization cycle outcomes in patients with low luteinizing hormone levels after gonadotropin-releasing hormone antagonist administration. Fertil Steril 2011;96:898–904.Google Scholar
Revelli, A, Martiny, G, Delle Piane, L, et al. A critical review of bi-dimensional and three-dimensional ultrasound techniques to monitor follicle growth: do they help improving IVF outcome? Reprod Biol Endocrinol 2014;12:107.Google Scholar
Ectors, FJ, Vanderzwalmen, P, Van Hoeck, J, et al. Relationship of human follicular diameter with oocyte fertilization and development after in-vitro fertilization or intracytoplasmic sperm injection. Hum Reprod 1997;12:2002–2005.Google Scholar
Kolibianakis, EM, Albano, C, Camus, M, et al. Prolongation of the follicular phase in in vitro fertilization results in a lower ongoing pregnancy rate in cycles stimulated with recombinant follicle-stimulating hormone and gonadotropin-releasing hormone antagonists. Fertil Steril 2004;82:102–107.Google Scholar
Abbara, A, Clarke, SA, Dhillo, WS. Novel concepts for inducing final oocyte maturation in in vitro fertilization treatment. Endocr Rev 2018;39:593–628.Google Scholar
Meyer, L, Murphy, LA, Gumer, A, et al. Risk factors for a suboptimal response to gonadotropin-releasing hormone agonist trigger during in vitro fertilization cycles. Fertil Steril 2015;104:637–642.Google Scholar
Griffin, D, Feinn, R, Engmann, L, et al. Dual trigger with gonadotropin releasing hormone agonist and standard dose human chorionic gonadotropin to improve oocyte maturity rates. Fertil Steril 2014;102:405–409.Google Scholar
Perez Mayorga, M, Gromoll, J, Behre, HM, et al. Ovarian response to follicle-stimulating hormone (FSH) stimulation depends on the FSH receptor genotype. J Clin Endocrinol Metab 2000;85:3365–3369.Google Scholar
Simoni, M, Nieschlag, E, Gromoll, J. Isoforms and single nucleotide polymorphisms of the FSH receptor gene: implications for human reproduction. Hum Reprod Update 2002;8:413–421.Google Scholar
Mohiyiddeen, L, Newman, WG, McBurney, H, et al. Follicle-stimulating hormone receptor gene polymorphisms are not associated with ovarian reserve markers. Fertil Steril 2012;97:677–681.Google Scholar
Alviggi, C, Clarizia, R, Pettersson, K, et al. Suboptimal response to GnRHa long protocol is associated with a common LH polymorphism. Reprod Biomed Online 2009;18:9–14.Google Scholar
Alviggi, C, Pettersson, K, Longobardi, S, et al. A common polymorphic allele of the LH beta-subunit gene is associated with higher exogenous FSH consumption during controlled ovarian stimulation for assisted reproductive technology. Reprod Biol Endocrinol 2013;1:51.Google Scholar
Lu, X, Yan, Z, Cai, R, et al. Pregnancy and live birth in women with pathogenic LHCGR variants using their own oocytes. J Clin Endocrinol Metab 2019;104:5877–5892.CrossRefGoogle ScholarPubMed
Chen, Q, Wang, Y, Sun, L, et al. Controlled ovulation of the dominant follicle using progestin in minimal stimulation in poor responders. Reprod Biol Endocrinol 2017;15:71.Google Scholar
Chen, Q, Chai, W, Wang, Y, et al. Progestin vs. gonadotropin-releasing hormone antagonist for the prevention of premature luteinizing hormone surges in poor responders undergoing in vitro fertilization treatment: a randomized controlled trial. Front Endocrinol (Lausanne) 2019;10:796.Google Scholar
Lainas, TG, Sfontouris, IA, Venetis, CA, et al. Live birth rates after modified natural cycle compared with high-dose FSH stimulation using GnRH antagonists in poor responders. Hum Reprod 2015;30:2321–2330.Google Scholar
Patrizio, P, Vaiarelli, A, Levi Setti, PE, et al. How to define, diagnose and treat poor responders? Responses from a worldwide survey of IVF clinics. Reprod Biomed Online 2015;30:581–592.Google Scholar
Wu, YG, Barad, DH, Kushnir, VA, et al. Aging-related premature luteinization of granulosa cells is avoided by early oocyte retrieval. J Endocrinol 2015;226:167–180.Google Scholar
Wu, YG, Barad, DH, Kushnir, VA, et al. With low ovarian reserve, highly individualized egg retrieval (HIER) improves IVF results by avoiding premature luteinization. J Ovarian Res 2018;11:23.Google Scholar
Souza, ALM, Sampaio, M, Noronha, GB, et al. Effect of follicular flushing on reproductive outcomes in patients with poor ovarian response undergoing assisted reproductive technology. J Assist Reprod Genet 2017;34:1353–1357.Google Scholar
Koning, CH, Popp-Snijders, C, Schoemaker, J, Lambalk, CB. Elevated FSH concentrations in imminent ovarian failure are associated with higher FSH and LH pulse amplitude and response to GnRH. Hum Reprod 2000;15:1452–1456.Google Scholar
Lukaszuk, K, Kunicki, M, Liss, J, Bednarowska, A, Jakiel, G. Probability of live birth in women with extremely low anti-Müllerian hormone concentrations. Reprod Biomed Online 2014;28:64–69.CrossRefGoogle ScholarPubMed
Zhang, Y, Zhang, C, Shu, J, et al. Adjuvant treatment strategies in ovarian stimulation for poor responders undergoing IVF: a systematic review and network meta-analysis. Hum Reprod Update 2020;26:247–263.Google Scholar

Accessibility standard: Unknown

Why this information is here

This section outlines the accessibility features of this content - including support for screen readers, full keyboard navigation and high-contrast display options. This may not be relevant for you.

Accessibility Information

Accessibility compliance for the PDF of this book is currently unknown and may be updated in the future.

Save book to Kindle

To save this book to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×